CRBN and acute myeloid leukemia: Similarly, mutations in the core components of the VHL or CRBN E3 complexes were observed following prolonged exposure of AML (SKM1, MV4-11), ovarian cancer (OVCAR8), or prostate cancer (LNCaP) cell lines to BET PROTACs [56].